Allergan's Attack On Drug Compounding Falls Flat
A California federal judge has rejected Allergan Inc.'s high-stakes effort to make many drug compounding activities unlawful, saying he will defer to the U.S. Food and Drug Administration's decision to allow...To view the full article, register now.
Already a subscriber? Click here to view full article